The standard dosing protocol is 1.6 to 3.2 milligrams per week, administered subcutaneously
Either way its been easier to loose the unnecessary pounds
Regulatory status as of July 26, 2026: The Pharmacy Compounding Advisory Committee issued favorable recommendations for BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, and an unfavorable recommendation for emideltide/DSIP
Topical effects are usually mild and local: redness, tingling, dryness, or transient irritation, more common above 4% concentration
But I believe it's a truly amazing product that you'll want to keep
Despite internet hype, the FDA does not approve BPC-157 for medical use and prohibits its sale for human consumption